Literature DB >> 7539410

Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific.

L B Gilleland1, H E Gilleland.   

Abstract

Peptide 9 (TDAYNQKLSERRAN) and peptide 10 (NATAEGRAINRRVE) represent surface-exposed epitopes of outer membrane protein F of Pseudomonas aeruginosa. Rats immunized with four intramuscular inoculations on days 0, 14, 28, and 42 with either peptide 9 or peptide 10 conjugated to keyhole limpet hemocyanin were afforded protection against pulmonary lesions when examined 7 days subsequent to challenge (day 56) via intratracheal inoculation of P. aeruginosa-containing agar beads. Peptide 9 shares considerable homology with other OmpA-related outer membrane proteins in various bacteria, whereas peptide 10 displays little homology with these other proteins. Antisera directed to peptide 9 reacted weakly with cell envelope proteins from the various other OmpA-associated bacteria upon immunoblot analysis. However, antisera directed to peptide 10 reacted only with Neisseria gonorrhoeae cell envelope proteins upon immunoblot analysis. Antisera to both peptides 9 and 10 reacted at minimal titers with whole cells of the various other bacteria in a whole-cell enzyme-linked immunosorbent assay (ELISA) but antisera to each of the peptides reacted at high titers when various strains of P. aeruginosa were used as the ELISA antigen. Antibodies to peptides 9 and 10 were protective, reactive to all strain of P. aeruginosa tested except for a protein F-deficient mutant, and functionally specific against pseudomonads.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539410      PMCID: PMC173309          DOI: 10.1128/iai.63.6.2347-2351.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane.

Authors:  N Gotoh; H Wakebe; E Yoshihara; T Nakae; T Nishino
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.

Authors:  J M Matthews-Greer; H E Gilleland
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

4.  Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.

Authors:  H E Gilleland; M G Parker; J M Matthews; R D Berg
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa.

Authors:  E E Hughes; L B Gilleland; H E Gilleland
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

6.  Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model.

Authors:  H E Gilleland; L B Gilleland; J M Matthews-Greer
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

7.  Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium.

Authors:  C R Gentry-Weeks; A L Hultsch; S M Kelly; J M Keith; R Curtiss
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

8.  Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.

Authors:  J D Klinger; H A Cash; R E Wood; J J Miler
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  G B Pier; D Desjardins; T Aguilar; M Barnard; D P Speert
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

10.  Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.

Authors:  H E Gilleland; L B Gilleland; M R Fowler
Journal:  J Med Microbiol       Date:  1993-02       Impact factor: 3.196

View more
  14 in total

1.  Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.

Authors:  E Rosenqvist; A Musacchio; A Aase; E A Høiby; E Namork; J Kolberg; E Wedege; A Delvig; R Dalseg; T E Michaelsen; J Tommassen
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Pseudomonas aeruginosa porin OprF exists in two different conformations.

Authors:  Etsuko Sugawara; Ekaterina M Nestorovich; Sergey M Bezrukov; Hiroshi Nikaido
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

3.  Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.

Authors:  B M Price; D R Galloway; N R Baker; L B Gilleland; J Staczek; H E Gilleland
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Authors:  J K Pullen; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.

Authors:  Tanweer S Zaidi; Gregory P Priebe; Gerald B Pier
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

Authors:  M Vasfi Marandi; K R Mittal
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody.

Authors:  D C Webb; A W Cripps
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

8.  Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

Authors:  Stefan Worgall; Anja Krause; JianPing Qiu; Ju Joh; Neil R Hackett; Ronald G Crystal
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.

Authors:  H E Gilleland; E E Hughes; L B Gilleland; J M Matthews-Greer; J Staczek
Journal:  Curr Microbiol       Date:  1995-11       Impact factor: 2.188

10.  A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.

Authors:  J Staczek; H E Gilleland; L B Gilleland; R N Harty; A García-Sastre; O G Engelhardt; P Palese
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.